References 565% CONFIDENCEOverall confidence: 65%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidence

The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.

• [1]50%
  sec.gov/Archives/edgar/data/200406/000020040626000153/jnj-20260628.htm

  sec.gov· Posted Sep 23, 2026· Starts Jul 1, 2027· 26% of score

  J&J's 10-Q for the quarter to 28 June 2026 targets "completion within 18 to 24 months after the initial announcement" of 14 October 2025 (mid-April to mid-October 2027), and CFO Joseph Wolk said in July that J&J "is on track for a mid-2027 separation" (Bloomberg); "mid-2027" is read as the middle of the year, 1 July 2027, which sits inside that window.

• [2]72%
  Johnson & Johnson is in talks to sell its orthopedics business to Apollo for $20 billion

  qz.com· Published Sep 14, 2026· 25% of score

  Quartz: Wolk "noted that a mid-2027 separation timeline remains intact"; J&J could spin the unit off rather than sell it (per the WSJ).^[1]

• [3]80%
  Apollo Global Is Said in Talks to Acquire J&J's Orthopedics Unit (Bloomberg)

  finance.yahoo.com· Published Sep 11, 2026· Starts Jul 1, 2027 ✓· 24% of score

  Bloomberg, 11 September 2026: CFO Joseph Wolk said on the July earnings call that J&J "is on track for a mid-2027 separation", the newest company timing, read as 1 July 2027; also reports the Apollo talks.^[1]

• [4]80%
  DePuy Synthes names CFO ahead of J&J split

  medtechdive.com· Published Jun 30, 2026· 18% of score

  MedTech Dive, 30 June 2026: Christina Zamarro named DePuy Synthes CFO ahead of the separation; J&J reaffirmed in April the 18-to-24-month target and booked $119M of spinoff costs in Q1.

• [5]90%
  Johnson & Johnson announces intent to separate its Orthopaedics business (Form 8-K Exhibit 99.3)

  sec.gov· Published Oct 14, 2025· 7% of score

  J&J's original announcement as filed with the SEC^[1]: the Company "is targeting completion within 18 to 24 months", subject to works councils, board approval and regulatory approvals.

Suggest a correction

Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most. A picture that shows something else, or shows it badly, is looked at too, and moved down or replaced.